Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe page no longer shows the disease label 'Multiple myeloma' and the 'related topics' section that included MedlinePlus Genetics. This removes disease-specific context and a related informational resource from the study details page.SummaryDifference0.1%

- Check9 days agoChange DetectedUpdated the page’s footer/version marker to a newer release and added entries under the “related topics” section (e.g., MedlinePlus Genetics). This reflects supplementary site metadata/navigation rather than substantive changes to the clinical trial information.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRemoved the 'Multiple myeloma' condition label and the related topics section, including the 'MedlinePlus Genetics' link.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.